Troriluzole (BHV-4157) in Adult Participants With Obsessive Compulsive Disorder
Clinical trial NCT03299166 · COMPLETED
Trial details
- NCT number
- NCT03299166
- Sponsor
- Biohaven Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-19
- Primary completion
- 2020-06-02
- Enrollment
- 426
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.